PYC Therapeutics Limited (ASX:PYC)

PYC Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 28, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	672	560	191	207	493	337
Market Cap Growth	50.00%	192.66%	-7.47%	-58.06%	46.25%	375.89%
Enterprise Value	624	536	175	165	438	311
Last Close Price	1.22	1.18	0.55	0.63	1.51	1.11
PS Ratio	21.40	25.38	12.10	12.89	160.37	140.72
PB Ratio	10.27	6.91	6.73	5.14	9.14	11.17
P/TBV Ratio	11.96	7.33	8.14	5.92	10.19	14.28
EV/Sales Ratio	24.99	24.29	11.10	10.26	142.63	129.81
Debt / Equity Ratio	0.02	0.01	0.01	0.02	0.01	0.03
Asset Turnover	0.46	0.34	0.38	0.31	0.07	0.13
Quick Ratio	5.41	9.32	3.79	8.93	15.68	36.15
Current Ratio	5.46	9.40	3.79	8.95	15.71	36.23
Return on Equity (ROE)	-112.79%	-69.61%	-68.05%	-30.37%	-44.29%	-38.80%
Return on Assets (ROA)	-58.01%	-37.83%	-35.49%	-17.29%	-26.20%	-23.88%
Return on Capital (ROIC)	-71.07%	-43.79%	-41.90%	-18.64%	-27.38%	-24.49%
Earnings Yield	-7.17%	-6.74%	-11.91%	-6.71%	-3.60%	-2.02%
FCF Yield	-7.37%	-6.95%	-13.02%	-10.72%	-2.51%	-1.74%
Buyback Yield / Dilution	-25.01%	-22.59%	-0.93%	-2.89%	-12.58%	-17.18%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.